SCHEMBL3741807

SCHEMBL3741807

C[C@@H](N)[C@@H](C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3347623 1.00
SCHEMBL472255 1.00
SCHEMBL1773891 1.00
SCHEMBL8133423 1.00
SCHEMBL9668969 1.00 ALDH1A1 (0.42)
SCHEMBL5573654 1.00
Hydrochloric Acid SCHEMBL6365872 0.94
SCHEMBL1774778 0.94
Hydrochloric Acid SCHEMBL29467666 0.88
Isopropylamine SCHEMBL28067543 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9701684-B2 Chiral fluorinating reagents OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2017-07-11 US disclosed
US-20150284401-A1 CHIRAL FLUORINATING REAGENTS OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2015-10-08 US disclosed
US-20120208809-A1 9H-PYRROLO[2,3-B: 5,4-C'] DIPYRIDINE AZACARBOLINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-08-16 US disclosed
US-7943793-B2 Optically active organic acidate-bridged dinuclear platinum(II) complex OSAKA UNIVERSITY (JP) 2011-05-17 US disclosed
US-7943793-B2 Optically active organic acidate-bridged dinuclear platinum(II) complex OSAKA UNIVERSITY (JP) 2011-05-17 US disclosed
US-7834006-B2 antidiabetics; lower blood glucose levels; compounds based on 1H,2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-e][1,4]diazepin-6-one AJINOMOTO CO., INC. (JP) 2010-11-16 US disclosed
US-7834006-B2 antidiabetics; lower blood glucose levels; compounds based on 1H,2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-e][1,4]diazepin-6-one AJINOMOTO CO., INC. (JP) 2010-11-16 US disclosed
US-7834006-B2 antidiabetics; lower blood glucose levels; compounds based on 1H,2H,3H,4H,5H,6H,7H,8H-pyrrolo[3,4-e][1,4]diazepin-6-one AJINOMOTO CO., INC. (JP) 2010-11-16 US disclosed
US-20100121090-A1 OPTICALLY ACTIVE ORGANIC ACIDATE-BRIDGED DINUCLEAR PLATINUM(II) COMPLEX OSAKA UNIVERSITY (JP) 2010-05-13 US disclosed
US-20100121090-A1 OPTICALLY ACTIVE ORGANIC ACIDATE-BRIDGED DINUCLEAR PLATINUM(II) COMPLEX OSAKA UNIVERSITY (JP) 2010-05-13 US disclosed
EP-1601635-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL IN THE PRESENCE OF RHODIUM, A CHIRAL FERROCENYLDIPHOSPHINE AND AN OPTICALLY ACTIVE DIAMINE KAWAKEN FINE CHEMICALS CO (JP) 2008-01-09 EP disclosed
US-20060258637-A1 Fused polycyclic compounds AJINOMOTO CO. INC (JP) 2006-11-16 US disclosed
EP-1707567-A1 NOVEL FUSED-RING COMPOUND Ajinomoto Co., Inc. (JP) 2006-10-04 EP disclosed
EP-1469005-B1 Process for the asymmetric hydrogenation of ketocarbonic acid esters SALTIGO GMBH (DE) 2006-08-30 EP disclosed
EP-1377552-B1 METAL COMPLEXES AND THERAPEUTIC USES THEREOF UNIV SYDNEY (AU) 2006-05-17 EP disclosed
US-20040220165-A1 Process for asymmetrically hydrogenating keto carboxylic esters LANXESS DEUTSCHLAND GMBH (DE) 2004-11-04 US disclosed
US-20040220347-A1 Process for reducing ketocarboxylic esters LANXESS DEUTSCHLAND GMBH (DE) 2004-11-04 US disclosed
EP-1469006-A2 Process for the reduction of ketocarbonic acid esters Bayer Chemicals AG (DE) 2004-10-20 EP disclosed
EP-1469005-A1 Process for the asymmetric hydrogenation of ketocarbonic acid esters Bayer Chemicals AG (DE) 2004-10-20 EP disclosed
US-20040152686-A1 Metal complexes and therapeutic uses thereof THE UNIVERSITY OF WESTERN SYDNEY (AU) 2004-08-05 US disclosed